1.Study on immunosuppressive effect of Tongbizhitong Capsule
Luhua CAO ; Yingkun DU ; Xiaoro WANG
Chinese Traditional Patent Medicine 1992;0(03):-
AIM: To study immunosuppressive effects of Tongbizhitong Capsule. To reveal the anti-inflammatory mechanism of this capsule. METHODS : The anti-inflammatory effect was determined with the adjuvant arthritis models of the rats with adjuvant arthris (AA) paw edema. We also observed the blood oxygen free radican,nitric oxide(NO) with AA. The immunosuppressive effect was determined with T-cell subsets in spleen of rats with AA,serum haemolysin level of mouse,the delayed type hypersensitivity. RESULTS : Tongbizhitong Capsule had remarkable inhibitory effect on carrageenine induced granulation and on the prevention of AA. In the T-cell subsets: low,middle and high dose decreased T_h and high dose inhibited both T_s and T_h preacted mainly on T_h and rendered the decreased ratio of T_h/T_s. The delayed type hypersensitivity reaction was distinctly suppressed. It also had a suppressive action on serum haemolsin. Only the high dose could decrease serum lipid deroxides and NO contents,and increase superoxide dismutase and glutathione peroxidase levels. CONCLUSION : Tongbizhitong Capsule has suppressive effect on immune function.
2.Application of Fluorescence Quantitative PCR in Salmonella Rapid Detection in Drugs
Tingting LIU ; Luhua WANG ; Zunwen WANG ; Shizhen ZHU
China Pharmacist 2014;(2):242-244
Objective:To establish a Taqman fluorescence quantitative PCR for the detection of Salmonella in drugs. Methods:Based on Salmonella specific gene, a pair of primers and a probe were designed, and DNA of Salmonella was extracted for the detec-tion. Results:The method was much specific, and the detection limit was 160 cfu/ml. The detection rate was 100% for the artificially contaminated samples. Conclusion:Fluorescence quantitative PCR can be applied in the rapid detection of Salmonella in drugs.
3.Progress in charged particle therapy
Wenlong XIA ; Weigang HU ; Jianrong DAI ; Luhua WANG
Chinese Journal of Radiation Oncology 2017;26(8):951-955
Charged particle therapy offers a better effect and obvious dosimetric and biological advantages over conventional radiotherapy in tumor control.Charged particles form Bragg peak in the dose distribution in tissue, enable most of energy to be deposited in the target region, and thus enhance tumor control and reduce the damage to normal tissues surrounding the tumor.With the increasing demand for charged particle therapy and the advances in particle accelerator, particle therapy technology is developing rapidly.The core apparatus of particle therapy facility is particle accelerator, and the accelerator type, particle type, and implementation technique determine the performance and therapeutic effect of the facility.This article provides a detailed comparative analysis of various particle therapies.Statistical data show that proton therapy is dominant in particle therapy, and high construction difficulty, large facility size, and extremely high cost have limited the development of heavy ion therapy.Nowadays, there are still some technical problems regarding charged particle therapy, and more clinical trials are required.
4.Comparison of dose distribution between simplified IMRT and different curative radiotherapy plans for locally advanced non-small cell lung cancer
Hua REN ; Ke ZHANG ; Luhua WANG ; Jianrong DAI
Chinese Journal of Radiation Oncology 2009;18(5):357-360
ce, sIMRT and IMRT radiotherapy techniques can protect the lung and spinal cord well.
5.Study on fingerprints of Radix Salviae Miltiorrhiza and its INJECTION by HPLC-MS
Zunjian ZHANG ; Qian LI ; Wei WANG ; Qiaogen ZOU ; Luhua ZHAO
Chinese Traditional and Herbal Drugs 1994;0(12):-
Object To investigate the chromatographic fingerprints of Radix Salviae Miltiorrhizae (RSM), its intermediate and INJECTION by HPLC-UV-MS. Methods Separation was performed on an Alltima C 18 analytical column with the mobile phase consisting of methanol-water-acetic acid as gradient eluent at the flow rate of 1 mL/min. The UV detection was set at 281 nm and TIC was recorded by an electrospray ionization mass spectrometer in negative ion mode. Results The HPLC-UV and HPLC-MS fingerprints of RSM, its intermediate and INJECTION were obtained with perfect isolation. Conclusion The fingerprints could be used for the control of RSM, its intermediate and INJECTION.
6.Value of 18FDG PET-CT in the determination of treatment regimen in lung cancer
Wenjie ZHANG ; Rong ZHENG ; Ning WU ; Luhua WANG ; Yexiong LI ; Jing LI ; Ying LIU ; Ping ZHAO
Chinese Journal of Radiation Oncology 2009;18(5):367-371
can improve the accuracy of clinical staging and help to choose a proper treatment regimen. Moreover, it can clearly differentiate tumor from normal tis-sue and reduce the risk of geographic misses.
7.Design, synthesis and biological study of BTK/JAK3 dual-target inhibitors
Lifang CEN ; Ming CHENG ; Weijie REN ; Liu YE ; Luhua WANG ; Weibo GUO ; Qiang ZHANG ; Yungen XU
Journal of China Pharmaceutical University 2024;55(1):73-86
Abstract: In the present study, the compound XL-12 from our previous work was utilized as a lead compound. Through the optimization of the terminal phenyl ring, 12 target compounds were designed and synthesized. The structures of all target compounds were confirmed by 1H NMR, 13C NMR, and H RMS. In vitro enzyme activity assay showed that most compounds demonstrated significant inhibitory activity toward Bruton’s tyrosine kinase (BTK) and Janus kinase 3 (JAK3). Among them, compound I-3 exhibited moderate cell proliferation inhibitory activity toward Daudi cells and BaF3-JAK3 cells. In the evaluation of anti-inflammatory activity in vitro, compound I-3 could effectively inhibit the production of inflammatory factors IL-6; besides, it exhibited superior anti-inflammatory activity compared to ibrutinib in xylene-induced ear swelling model in mice.
8.Risk factors for radiation pneumonitis in patients with non-small-cell lung cancer treated with postoperative three-dimensional conformal radiotherapy
Wei JI ; Luhua WANG ; Gnangfei OU ; Jun HANG ; Qinfu FENG ; Dongfu CHEN ; Zongmei ZHOU ; Hongxing ZHANG ; Zefen XIAO ; Weibo YIN
Chinese Journal of Radiation Oncology 2009;18(4):274-277
Objective To evaluate the relation between lung dosimetric parameters and the risk of symptomatic radiation pneumonitis (RP) in patients with non-small cell lung cancer (NSCLC) who had re-ceived postoperative radiotherapy. Methods From November 2002 to March 2006, 90 patients with NSCLC who had received postoperative 3-dimentinal conformal radiotherapy (3DCRT) were retrospectively analyzed, including 53 with stage ⅢA disease, 25 with stafe ⅢB disease and 12 with stage Ⅰ-Ⅱ disease but positive margins. Seventy (78%) patients underwent lobectomy, 20 ( 22% ) underwent pneumonectomy, and 38 ( 46% ) received adjuvant chemotherapy. The median radiation dose was 60 Gy given in 30 fractions of 2 Gy using 6 MV X-ray. The percentage of the whole lung volume ( Vx ) and the ipsilateral absolute lung volume ( Vipsi-dosewhich received more than a certain dose were calculated. The endpoint was grade 2 and above RP based on CTC AE 3.0. The relation between the dosimetric factors and RP was also analyzed with receiver operating characteristic (ROC) curves. Results Nine patients ( 10% ) developed symptomatic RP ( grade 2 in 7 and grade 3 in 2), and all of them were in the lobectomy group. No RP was observed in patients who received pneumonectomy. Both V30 and V35 were higher in patients with RP than those without ( 19% vs 14% ,U= -2.16,P=0.030, and 15% vs 11%,U= -2.65,P =0.007, respectively). The area under curve in receiver operating characteristic curves based on the relation between incidence of RP and the value of Vipsi-dose was 0. 757. Using Vipsi-30 of 340 cm3 as a cut-off to predict RP, the sensitivity and specificity were 88% and 70%, respectively. The incidence of RP was 3% in patients with Vipsi-30< 340 cm3 compared with 29% in those with Vipsi-30>340cm3 ( X2 = 9.75 , P = 0.003 ) . Conclusions More than340 cm3 of the ipsilateral lung receiving 30 Gy is significantly related to the risk of RP in patients undergoing lobectomy. It is safe for patients who undergo pneumonectomy to receive postoperative 3DCRT if lung V20 is less than 10%.
9.Association of single nucleotide polymorphisms with radiation-induced esophagitis
Li ZHANG ; Luhua WANG ; Ming YANG ; Wei JI ; Lujun ZHAO ; Weizhi YANG ; Zongmei ZHOU ; Guangfei OU ; Dongxin LIN
Chinese Journal of Radiation Oncology 2008;17(3):175-179
Objective To evaluate the relationship between single nucleotide polymorphism(SNP) of candidate genes and radiation-induced esophagitis (RIE) in patients with lung cancer. Methods Between Jan. 2004 and Aug. 2006,170 patients with pathologically diagnosed lung cancer were enrolled in this study. The total target dose was 45-70 Gy( median 60 Gy). One hundred and thirty-two patients were treated with three-dimensional conformal radiotherapy(3DCRT) and 38 with two-dimensional radiotherapy(2DRT).Forty-one patients received radiotherapy alone, 78 received sequential chemoradiotherapy and 51 received concurrent chemoradiotherapy. Thirty-seven SNPs in 20 DNA repair genes were analyzed by using PCR-based restrieted fragment length polymorphism(RFLP). These genes were apoptosis and inflammatory cytoking genes including ATM, ERCC1, XRCC3, XRCC1, XPD, XPC, XPG, NBS1, STK15, ZNF350, ADPRT,TP53, FAS, FASL, CYP2D6 * 4, CASPASE8, COX2,TGF-β, CD14 and ACE. The endpoint was grade ≥2 R I E. Results Forty of the 170 patients developed grade ≥2 R I E, including 36 in grade 2 and 4 in grade 3. Univariate analysis revealed that radiation technique and concurrent chemoradiotherapy were statistically significant relatives to the incidence of R I E (P = 0. 032,0.049) , and both of them had the trend associating with the esophagitis( P = 0.072,0. 094 ). An increased incidence of esophagitis was observed associating with the TGF-β1-509T and XPD 751 Lys/Lys genotypes ( χ2 = 5.65, P = 0.017 ;χ2 = 3.84, P = 0. 048 )in multivariate analysis. Conclusions Genetic polymorphisms in TGF-β1 gene and XPD gene have a significant association with radiation-induced esophagitis.
10.Correlation of initial DNA damage detected by alkaline comet assay and clinical endpoints in lung cancer patients.
Jima LV ; Luhua WANG ; Weizhi YANG ; Xiaohua ZHANG ; Mianrong WANG ; Jie YAN
Chinese Journal of Lung Cancer 2006;9(2):187-191
BACKGROUNDCells derived from lung cancer are biological heterogeneous and have different intrinsic radiosensitivity, it is a key question for us to investigate radiosensitive parameters for an individualized radiotherapy plan. The comet assay is a sensitive and facilitated method to detect single-cell DNA damage and repair, and the results from it have been proven to be so highly coincident with those from clonogenic assay by cell-line investigations that it has been considered as a promising method in predicting radiosensitivity. The study is designed to evaluate preliminarily the correlation between initial DNA damage detected by alkaline comet assay and the clinical endpoints.
METHODSBiopsy samples from 31 lung cancer patients by fibrous bronchial endoscopy were detected by alkaline comet assay from April, 2002 to November, 2002. The adjusted tail moment (R TM) was measured and thoracic local-region lesions were measured by computer tomography scan. Response rate (RR) and time to progression (TTP) for the local-region lesions were as clinical endpoints. SPSS 10.0 software was used to compare median R TM of different RR and TTP groups by Mann-Whitney U and Kruskal-Wallis H rank test, the correlations between R TM with RR and TTP were estimated by Spearman's rank test.
RESULTSThere were no statistic differences of median R TM among different pathological types with a median R TM of 0.98, 1.27 and 1.05 in squamous cell carcinoma group, adenocarcinoma group and small cell lung cancer group, respectively (Chi-square=0.347, P=0.84). Through a median follow-up of 10 months, a median R TM of 1.08 and 1.21 for squamous cell carcinoma group and small cell lung cancer group in RR≥50% group was greater than 0.88 and 0.91 in RR < 50% group; median R TM in TTP > 9-monthgroups stratified according to pathological type was greater than that in TTP≤9-month groups (1.26, 1.38 and 1.39 versus 0.71, 0.48 and 1.03 for squamous cell carcinoma group, adenocarcinoma group and small cell lung cancer group respectively), but the differences of R TM classified by RR or TTP were not statistically significant (U=63.5, P=0.58; U=71, P=0.057); the Spearman's coefficients of R TM with RR and TTP were -0.105 (P=0.57) and 0.38 (P=0.035). The coefficients of R TM with TTP was 0.47 for non-small cell lung cancer indicating a modest correlation (P=0.048) and 0.043 for small cell lung cancer (P=0.89).
CONCLUSIONSAlthough the results are confounded due to sampling and the greater background tail moments, Spearman's coefficient of R TM with TTP for non-small cell lung cancer indicates a modest positive correlation. The comet assay might be a promising method in predicting intrinsic radiosensitivity of lung cancer cells and techniques for sampling and assaying need to be further improved.